Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'07
No of Months
12
Operating Income
130.00
Less :Inter divisional transfers
0.00
Less: Excise
9.00
Net Sales
120.00
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
Raw Materials Consumed
38.00
Power & Fuel Cost
3.00
Employee Cost
20.00
Operating Expenses
7.00
General and Administration Expenses
13.00
Selling and Distribution Expenses
5.00
Cost of Software developments
0.00
Miscellaneous Expenses
7.00
Expenses Capitalised
0.00
Total Expenditure
98.00
Operating Profit (PBDIT) excl Other Income
22.00
Other Income
3.00
Operating Profit (PBDIT)
26.00
Interest
11.00
Profit before Depriciation and Tax
14.00
Depreciation
4.00
Profit Before Taxation & Exceptional Items
9.00
Exceptional Income / Expenses
0.00
Profit Before Tax
9.00
Provision for Tax
1.00
Profit After Tax
8.00
Extraordinary Items
0.00
Adj to Profit After Tax
1.00
Profit Balance B/F
-10.00
Profit Available for appropriations
-1.00
Appropriations
-1.00
Equity Dividend (%)
15.00%
Earnings Per Share
5.75
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 12.26% vs 13.50% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 24.38% vs 24.74% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 10.42% vs 25.22% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 109.03% vs 29.60% in Mar 2024
Compare Profit and Loss Results of RPG LifeScience.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
130.00
2,711.00
-2,581.00
-95.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
9.00
0.00
9.00
0%
Net Sales
120.00
2,711.00
-2,591.00
-95.57%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-91.00
94.00
103.30%
Raw Materials Consumed
38.00
592.00
-554.00
-93.58%
Power & Fuel Cost
3.00
91.00
-88.00
-96.70%
Employee Cost
20.00
1,293.00
-1,273.00
-98.45%
Operating Expenses
7.00
130.00
-123.00
-94.62%
General and Administration Expenses
13.00
-1.00
14.00
1,400.00%
Selling and Distribution Expenses
5.00
32.00
-27.00
-84.38%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
7.00
-1.00
8.00
800.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
98.00
2,242.00
-2,144.00
-95.63%
Operating Profit (PBDIT) excl Other Income
22.00
468.00
-446.00
-95.30%
Other Income
3.00
21.00
-18.00
-85.71%
Operating Profit (PBDIT)
26.00
490.00
-464.00
-94.69%
Interest
11.00
159.00
-148.00
-93.08%
Profit before Depriciation and Tax
14.00
331.00
-317.00
-95.77%
Depreciation
4.00
293.00
-289.00
-98.63%
Profit Before Taxation & Exceptional Items
9.00
37.00
-28.00
-75.68%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
19.00
-10.00
-52.63%
Provision for Tax
1.00
16.00
-15.00
-93.75%
Profit After Tax
8.00
3.00
5.00
166.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
1.00
0.00
1.00
0%
Profit Balance B/F
-10.00
174.00
-184.00
-105.75%
Profit Available for appropriations
-1.00
177.00
-178.00
-100.56%
Appropriations
-1.00
177.00
-178.00
-100.56%
Equity Dividend (%)
15%
0%
15.00
Earnings Per Share
5.7526
0.21
5.54
2,639.33%
Profit And Loss - Net Sales
Net Sales 653.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.26% vs 13.50% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.62 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.38% vs 24.74% in Mar 2024
Profit And Loss - Interest
Interest 1.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.42% vs 25.22% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 183.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 109.03% vs 29.60% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
